Company Overview - Visa closed at $365.86, with a slight increase of +0.15% from the previous day, underperforming the S&P 500's gain of 0.58% [1] - Over the past month, Visa's shares have increased by 4.78%, surpassing the Business Services sector's gain of 3.69% and the S&P 500's gain of 4.61% [1] Upcoming Earnings - Visa is expected to report an EPS of $2.84, reflecting a growth of 17.36% compared to the same quarter last year [2] - Revenue is projected to be $9.85 billion, indicating a 10.7% increase from the equivalent quarter last year [2] Fiscal Year Estimates - For the entire fiscal year, earnings are estimated at $11.35 per share, with a revenue forecast of $39.61 billion, representing changes of +12.94% and +10.26% respectively from the previous year [3] - Recent changes in analyst estimates for Visa may indicate shifts in near-term business trends, with positive revisions suggesting analyst optimism [3][4] Valuation Metrics - Visa currently has a Forward P/E ratio of 32.18, which is a premium compared to the industry's average Forward P/E of 15.08 [6] - The PEG ratio for Visa stands at 2.46, while the Financial Transaction Services industry has an average PEG ratio of 1.17 [6] Industry Context - The Financial Transaction Services industry is part of the Business Services sector, holding a Zacks Industry Rank of 51, placing it in the top 21% of over 250 industries [7] - The top 50% rated industries tend to outperform the bottom half by a factor of 2 to 1 [7]

Freeport-McMoRan (FCX) ended the recent trading session at $40.24, demonstrating a +0.22% swing from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0.58% for the day. Elsewhere, the Dow saw an upswing of 0.51%, while the tech-heavy Nasdaq appreciated by 0.81%.Shares of the mining company have appreciated by 7.5% over the course of the past month, outperforming the Basic Materials sector's gain of 3.65% and the S&P 500's gain of 4.61%.The upcoming earnings ...

Company Performance - Astrazeneca's stock closed at $71.93, reflecting a -1.24% change from the previous day, underperforming the S&P 500 which gained 0.41% [1] - Over the past month, Astrazeneca's shares increased by 0.54%, outperforming the Medical sector's decline of 3.74% but lagging behind the S&P 500's rise of 6.13% [1] Upcoming Earnings - Astrazeneca is expected to report earnings of $1.11 per share, indicating a year-over-year growth of 12.12% [2] - The consensus estimate for quarterly revenue is projected at $14.03 billion, representing an 8.42% increase from the same period last year [2] Full Year Projections - For the full year, earnings are projected at $4.49 per share and revenue at $57.68 billion, showing increases of +9.25% and +6.67% respectively from the previous year [3] - Recent analyst estimate revisions suggest a favorable outlook on Astrazeneca's business health and profitability [3] Valuation Metrics - Astrazeneca's Forward P/E ratio is currently at 16.2, which is lower than the industry average of 20.51 [6] - The company has a PEG ratio of 1.34, compared to the industry average PEG ratio of 1.47 [6] Industry Context - Astrazeneca operates within the Medical - Biomedical and Genetics industry, which holds a Zacks Industry Rank of 74, placing it in the top 30% of over 250 industries [7] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - VALE S.A. closed at $9.27, reflecting a +1.53% change from the previous trading day's close, outperforming the S&P 500's gain of 0.41% [1] - Over the past month, VALE's shares have decreased by 2.56%, underperforming the Basic Materials sector's gain of 2.3% and the S&P 500's gain of 6.13% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $0.44, a 2.33% increase compared to the same quarter last year, with quarterly revenue anticipated at $10 billion, up 0.78% from the previous year [2] - For the full year, analysts expect earnings of $1.78 per share and revenue of $39.39 billion, representing changes of -2.2% and +3.5% respectively from last year [3] Analyst Estimates - Recent changes to analyst estimates for VALE S.A. indicate shifting business dynamics, with positive revisions suggesting analyst optimism regarding the company's profitability [4] - The Zacks Rank system, which evaluates estimate changes, currently ranks VALE S.A. at 3 (Hold), with a 1.55% decline in the Zacks Consensus EPS estimate over the past month [6] Valuation Metrics - VALE S.A. has a Forward P/E ratio of 5.14, which is in line with the industry average [7] - The company also has a PEG ratio of 0.29, matching the average PEG ratio for the Mining - Iron industry [8] Industry Context - The Mining - Iron industry, part of the Basic Materials sector, holds a Zacks Industry Rank of 92, placing it in the top 38% of over 250 industries [9]

Company Performance - Progressive closed at $288.74, marking a +1.34% move from the prior day, outperforming the S&P 500's daily gain of 0.41 [1] - The stock has risen by 0.75% in the past month, lagging behind the Finance sector's gain of 4.15% and the S&P 500's gain of 6.13% [1] Upcoming Earnings - Progressive is expected to report EPS of $3.85, up 45.28% from the prior-year quarter, with a revenue forecast of $21.47 billion, indicating a 17.6% growth compared to the corresponding quarter of the prior year [2] Full Year Estimates - For the full year, earnings are projected at $16.12 per share and revenue at $87.37 billion, reflecting changes of +14.73% and +16.33% from the preceding year [3] Analyst Projections - Recent revisions in analyst projections indicate optimism regarding Progressive's business and profitability, as positive alterations in estimates often reflect near-term business trends [3][4] Zacks Rank and Performance - Progressive holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate having moved 2.24% higher within the past month [5] - The Zacks Rank system has shown that 1 ranked stocks yield an average annual return of +25% since 1988 [5] Valuation Metrics - Progressive's Forward P/E ratio is 17.67, which is a premium compared to the industry average of 12.12 [6] - The company has a PEG ratio of 1.73, while the Insurance - Property and Casualty industry had an average PEG ratio of 2.78 [7] Industry Overview - The Insurance - Property and Casualty industry is part of the Finance sector and currently holds a Zacks Industry Rank of 55, placing it in the top 23% of all industries [8]

Core Viewpoint - AudioEye is expected to show strong earnings growth in its upcoming release, with projected EPS of $0.16 and revenue of $9.94 million, indicating significant year-over-year increases [2][3]. Company Performance - AudioEye's stock closed at $12.22, reflecting a slight decline of 0.81% from the previous day, underperforming the S&P 500's daily loss of 0.01% [1]. - Over the past month, AudioEye's shares gained 11.19%, outperforming the Computer and Technology sector's gain of 10.75% and the S&P 500's gain of 6.43% [1]. Earnings Estimates - The Zacks Consensus Estimates forecast earnings of $0.71 per share and revenue of $41.51 million for the entire year, representing increases of 29.09% and 17.91% respectively compared to the previous year [3]. - The EPS estimate has increased by 33.33% for the upcoming quarter compared to the same quarter last year [2]. Analyst Sentiment - Recent changes to analyst estimates for AudioEye indicate a positive outlook, reflecting analysts' confidence in the company's business performance and profit potential [4]. - The Zacks Rank for AudioEye is currently 2 (Buy), with a 6.67% increase in the consensus EPS estimate over the past month [6]. Valuation Metrics - AudioEye has a Forward P/E ratio of 17.48, which is lower than the industry's average Forward P/E of 28.91, suggesting it may be undervalued [7]. - The company has a PEG ratio of 0.7, significantly below the Internet - Software industry's average PEG ratio of 2.03, indicating favorable growth prospects relative to its valuation [8]. Industry Context - The Internet - Software industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 53, placing it in the top 22% of over 250 industries [9].

Core Investment Strategy - Value investing is highlighted as a reliable strategy during market volatility, allowing investors to purchase stocks at discounted prices when others sell [1][2] Value Investment Drawbacks - The concept of "value traps" is introduced, where stocks may underperform due to persistent issues rather than temporary problems [3] - Common metrics for value investing include dividend yield, P/E, and P/B ratios, which help identify discounted stocks [3] Importance of PEG Ratio - The PEG ratio, defined as (Price/Earnings)/Earnings Growth Rate, is emphasized as a crucial metric for assessing a stock's intrinsic value [4][5] - A low PEG ratio is preferred, but it has limitations, such as not accounting for changing growth rates over time [5] Screening Criteria for Value Stocks - Effective screening criteria for value stocks include: - PEG Ratio less than industry median - P/E Ratio less than industry median - Zacks Rank 1 (Strong Buy) or 2 (Buy) - Market Capitalization greater than $1 billion - Average 20-Day Volume greater than 50,000 - Percentage Change in F1 Earnings Estimate Revisions greater than 5% - Value Score of less than or equal to B [6] Selected Stocks - Urban Outfitters (URBN) is a lifestyle retailer with a Zacks Rank 1 and a five-year historical growth rate of 20% [9][8] - Dentsply Sirona (XRAY) is a leader in dental products with a Zacks Rank 2 and a long-term expected growth rate of 7.4% [10][11] - LATAM Airlines (LTM) offers extensive air transportation services with a Zacks Rank 1 and a five-year expected growth rate of 14.8% [11][12] - Exelixis (EXEL) focuses on cancer therapies with a long-term expected earnings growth rate of 21% and a Zacks Rank of 2 [12][13]

Company Performance - RH's stock closed at $184.14, showing a slight increase of +0.16% from the previous day, but underperformed compared to the S&P 500's gain of 0.4% [1] - Over the past month, RH's shares experienced a loss of 0.1%, lagging behind the Consumer Staples sector's gain of 1.13% and the S&P 500's gain of 6.69% [1] Earnings Forecast - The upcoming earnings report for RH is expected to show an EPS of -$0.09, which represents a significant increase of 77.5% compared to the same quarter last year [2] - Revenue is forecasted to be $818.86 million, indicating a growth of 12.64% year-over-year [2] Full Year Projections - For the full year, earnings are projected at $10.74 per share and revenue at $3.53 billion, reflecting increases of +99.26% and +11.08% respectively from the previous year [3] - Recent adjustments to analyst estimates for RH indicate a positive outlook, suggesting optimism regarding the company's business and profitability [3] Valuation Metrics - RH's current Forward P/E ratio stands at 17.12, which is lower than the industry average Forward P/E of 20.29, indicating a potential valuation discount [6] - The company has a PEG ratio of 0.55, significantly lower than the Consumer Products - Staples industry's average PEG ratio of 3.52, suggesting favorable growth expectations relative to its valuation [7] Industry Context - The Consumer Products - Staples industry, which includes RH, has a Zacks Industry Rank of 171, placing it in the bottom 31% of over 250 industries [8] - Historical data shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1, highlighting the competitive landscape within the sector [8]

Company Overview - PepsiCo's stock closed at $131.92, reflecting a gain of +0.96% from the previous trading session, outperforming the S&P 500's daily gain of 0.4% [1] - Over the past month, PepsiCo's shares have declined by 3.62%, underperforming the Consumer Staples sector's gain of 1.13% and the S&P 500's gain of 6.69% [1] Upcoming Earnings - PepsiCo is projected to report earnings of $2.04 per share, indicating a year-over-year decline of 10.53% [2] - The consensus estimate for revenue is $22.37 billion, reflecting a 0.6% decline compared to the same quarter last year [2] Full Year Projections - For the full year, earnings are estimated at $7.87 per share, representing a decline of 3.55%, while revenue is projected at $92.2 billion, showing a slight increase of 0.38% from the previous year [3] Analyst Estimates and Rankings - Recent adjustments to analyst estimates for PepsiCo indicate evolving short-term business trends, with positive revisions suggesting a favorable outlook on the company's health and profitability [4] - The Zacks Rank system currently rates PepsiCo at 4 (Sell), with a recent 0.18% decline in the Zacks Consensus EPS estimate [6] Valuation Metrics - PepsiCo's Forward P/E ratio stands at 16.6, which is below the industry average of 20.15 [7] - The PEG ratio for PepsiCo is 3.75, compared to the average PEG ratio of 2.54 for the Beverages - Soft drinks industry [7] Industry Context - The Beverages - Soft drinks industry is part of the Consumer Staples sector and holds a Zacks Industry Rank of 50, placing it in the top 21% of over 250 industries [8]

The most recent trading session ended with UnitedHealth Group (UNH) standing at $298.17, reflecting a +0.02% shift from the previouse trading day's closing. The stock lagged the S&P 500's daily gain of 0.4%. At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq gained 0.39%.Coming into today, shares of the largest U.S. health insurer had lost 27.55% in the past month. In that same time, the Medical sector lost 3.41%, while the S&P 500 gained 6.69%.The investment community will be paying close att ...